ICM
SFE

Invenomic Capital Management’s Safeguard Scientifics, Inc. SFE Stock Holding History

Invenomic Capital Management’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-64,563
Closed -$440K – 158
2021
Q1 		$440K Buy
+64,563
New +$469K 0.1% 101

Other funds holding SFE

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CP
Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invenomic Capital Management's SFE Position: Q2 2021 in Review

Invenomic Capital Management sold out of Safeguard Scientifics, Inc. (SFE) in Q2 2021, closing a stake of 64,563 shares — an estimated $440K sold.

Invenomic Capital Management first reported a position in SFE in Q1 2021 and held it in 1 quarter. The position peaked at $440K in Q1 2021. 76 funds tracked by Wall St. Rank hold SFE as of Q2 2021.

  • Invenomic Capital Management reported no remaining Safeguard Scientifics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 64,563 Safeguard Scientifics, Inc. shares in Q2 2021, an estimated $440K.
  • Invenomic Capital Management first reported a position in Safeguard Scientifics, Inc. in Q1 2021 and held it in 1 quarter.
  • Invenomic Capital Management's Safeguard Scientifics, Inc. position peaked at $440K in Q1 2021.
  • 76 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q2 2021.

Based on Invenomic Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.